Optimal treatment of Alzheimer's disease psychosis: challenges and solutions.
about
Cortical brain volume abnormalities associated with few or multiple neuropsychiatric symptoms in Alzheimer's diseaseAgitation and Irritability in Alzheimer's Disease: Evidenced-Based Treatments and the Black-Box Warning.Pharmacological Effects of Active Components of Chinese Herbal Medicine in the Treatment of Alzheimer's Disease: A Review.Haloperidol inactivates AMPK and reduces tau phosphorylation in a tau mouse model of Alzheimer's diseaseHuannao Yicong Formula () regulates γ-secretase activity through APH-1 and PEN-2 gene ragulation pathways in hippocampus of APP/PS1 double transgenic mice.
P2860
Optimal treatment of Alzheimer's disease psychosis: challenges and solutions.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Optimal treatment of Alzheimer's disease psychosis: challenges and solutions.
@ast
Optimal treatment of Alzheimer's disease psychosis: challenges and solutions.
@en
type
label
Optimal treatment of Alzheimer's disease psychosis: challenges and solutions.
@ast
Optimal treatment of Alzheimer's disease psychosis: challenges and solutions.
@en
prefLabel
Optimal treatment of Alzheimer's disease psychosis: challenges and solutions.
@ast
Optimal treatment of Alzheimer's disease psychosis: challenges and solutions.
@en
P2860
P356
P1476
Optimal treatment of Alzheimer's disease psychosis: challenges and solutions.
@en
P2093
Blaine S Greenwald
Jeremy Koppel
P2860
P304
P356
10.2147/NDT.S60837
P407
P577
2014-11-24T00:00:00Z